FDA Requests Antidepressant Labeling Add Suicidality Warning
Executive Summary
FDA is requesting that labeling for 10 antidepressants include a warning recommending close monitoring of adult and pediatric patients for suicidal behavior
You may also be interested in...
Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant
Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant
GSK Wellbutrin XL Ad Notes Suicidality Risk, Does Not Reflect “Black Box”
A new GlaxoSmithKline television ad for the antidepressant Wellbutrin XL includes information about suicidality and mood changes